Benralizumab for eosinophilic granulomatosis with polyangiitis

Cottu, A; Groh, M; Desaintjean, C; Marchand-Adam, S; Guillevin, L; Puechal, X; Beaumesnil, S; Lazaro, E; Samson, M; Taille, C; Durel, CA; Diot, E; Nicolas, S; Guilleminault, L; Ebbo, M; Cathebras, P; Dupin, C; Yildiz, H; Belfeki, N; Pugnet, G; Chauvin, P; Jouneau, S; Lifermann, F; Martellosio, JP; Cottin, V; Terrier, B

Terrier, B (通讯作者)，Hosp Cochin, Natl Referral Ctr Rare Syst Autoimmune Dis, Dept Internal Med, F-75014 Paris, France.;Terrier, B (通讯作者)，Hosp Cochin, Natl Referral Ctr Rare Syst Autoimmune Dis, Dept Internal Med, Paris, France.

ANNALS OF THE RHEUMATIC DISEASES, 2023; ():

Abstract

BackgroundBenralizumab is effective in the treatment of eosinophilic asthma and is being investigated for the treatment of other eosinophil-associated......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索